Chemokines in tumor progression and metastasis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Richmond, 2011, Chemokines in health and disease, Exp. Cell Res, 317, 575, 10.1016/j.yexcr.2011.01.005
Yoshie, 2000, Chemokines: a new classification system and their role in immunity, Immunity, 12, 121, 10.1016/S1074-7613(00)80165-X
Power, 2000, International union of pharmacology. XXII. Nomenclature for chemokine receptors, Pharmacol. Rev, 52, 145
Proudfoot, 2011, Overcoming hurdles in developing successful drugs targeting chemokine receptors, Nat Rev Immunol, 11, 355, 10.1038/nri2972
Ley, 2002, Chemokines and chemokine receptors in leukocyte trafficking, Am. J. Physiol, 283, R7
Van Damme, 2006, Natural post-translational modifications of chemokines, Biochem. Soc. Trans, 34, 997
Proost, 2008, Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation, Blood, 112, 2648, 10.1182/blood-2008-04-149039
Proost, 2009, Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4, J. Immunol, 182, 666, 10.4049/jimmunol.182.1.666
Proost, 2009, Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation, Haematologica, 94, 1346, 10.3324/haematol.2009.006973
Richmond, 2002, Nf-kappa B, chemokine gene transcription and tumour growth, Nat Rev Immunol, 2, 664, 10.1038/nri887
Peeper, 2006, Oncogene-induced cell senescence--halting on the road to cancer, N. Engl. J. Med, 355, 1037, 10.1056/NEJMra062285
Campisi, 2009, Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network, Proc. Natl. Acad. Sci. U. S. A, 106, 17031, 10.1073/pnas.0905299106
Gil, 2008, Chemokine signaling via the CXCR2 receptor reinforces senescence, Cell, 133, 1006, 10.1016/j.cell.2008.03.038
Peeper, 2008, Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network, Cell, 133, 1019, 10.1016/j.cell.2008.03.039
Gaffney, 2004, Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck, Cancer Res, 64, 55, 10.1158/0008-5472.CAN-03-2144
Gil, 2009, A role for CXCR2 in senescence, but what about in cancer?, Cancer Res, 69, 2167, 10.1158/0008-5472.CAN-08-3772
Weinberg, 2009, The basics of epithelial-mesenchymal transition, J. Clin. Invest, 119, 1420, 10.1172/JCI39104
Mercurio, 2004, The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis, Exp. Cell Res, 299, 315, 10.1016/j.yexcr.2004.05.033
Fabregat, 2009, Role of CXCR4/SDF-1 alpha in the migratory phenotype of hepatoma cells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-beta, Cell. Signal, 21, 1595, 10.1016/j.cellsig.2009.06.006
Palena, IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells, Cancer Res, 71, 5296
Wang, Role of chemokine receptor CXCR7 in bladder cancer progression, Biochem. Pharmacol, 84, 204
Wang, SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells, Gastroenterology, 141, 279, 10.1053/j.gastro.2011.04.008
Korach, 2003, Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells, Mol. Endocrinol, 17, 792, 10.1210/me.2002-0438
Balkwill, 2001, Epithelial cancer cell migration: a role for chemokine receptors?, Cancer Res, 61, 4961
Yong, 2002, CXCR4 is a major chemokine receptor on glioma cells and mediates their survival, J. Biol. Chem, 277, 49481, 10.1074/jbc.M206222200
Schettini, 2003, Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt, Cancer Res, 63, 1969
Salgia, 2002, Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells, Cancer Res, 62, 6304
Martinelli, 2002, CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma, Cancer Res, 62, 3106
Bendall, 2003, Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro, Leukemia, 17, 1294, 10.1038/sj.leu.2402998
Kipps, 2000, Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1, Blood, 96, 2655, 10.1182/blood.V96.8.2655
Saltiel, 1999, Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo, Nat. Med, 5, 810, 10.1038/10533
Thomas, 1986, Purification of melanoma growth stimulatory activity, J. Cell. Physiol, 129, 375, 10.1002/jcp.1041290316
Bendall, 2005, Chemokines and their receptors in disease, Histol. Histopathol, 20, 907
Balkwill, 2004, Cancer and the chemokine network, Nature reviews, 4, 540
Peled, 2004, Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis, FASEB J, 18, 1240, 10.1096/fj.03-0935fje
Fricker, CXCL12 (SDF-1)/CXCR4 pathway in cancer, Clin. Cancer Res, 16, 2927
Zlotnik, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016
Pei, 2002, Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation, J. Biol. Chem, 277, 49212, 10.1074/jbc.M207294200
Krek, 2003, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL, Nature, 425, 307, 10.1038/nature01874
Imamura, 2000, Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression, Clin. Cancer Res, 6, 3530
Gutierrez, 2000, Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma, Clin. Cancer Res, 6, 102
Este, 2003, CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease, Ann. Hematol, 82, 500, 10.1007/s00277-003-0679-0
Yoshie, The evolution of mammalian chemokine genes, Cytokine Growth Factor Rev, 21, 253
Kipps, Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib, Blood, 117, 882
Parker, 2006, A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer, Cancer Res, 66, 3071, 10.1158/0008-5472.CAN-05-2871
Tahara, 2000, Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8, Clin. Cancer Res, 6, 2735
Singh, 2009, CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion, Br. J. Cancer, 100, 1638, 10.1038/sj.bjc.6605055
Keilholz, 2009, The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer, Int. J. Cancer, 125, 741, 10.1002/ijc.24468
Farber, 2009, The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers, PloS one, 4, e6695, 10.1371/journal.pone.0006695
Chung, 2011, Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer, Molecular medicine reports, 4, 419
Hwang, 2003, Immune evasion by murine melanoma mediated through CC chemokine receptor-10, J. Exp. Med, 198, 1337, 10.1084/jem.20030593
Ferris, 2008, Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy, J. Natl. Cancer Inst, 100, 502, 10.1093/jnci/djn059
Mukaida, 2003, Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas, Am. J. Pathol, 162, 1249, 10.1016/S0002-9440(10)63921-1
Martinez, 2003, CCR5 expression influences the progression of human breast cancer in a p53-dependent manner, J. Exp. Med, 198, 1381, 10.1084/jem.20030580
Marriott, 1995, The functional role of the ELR motif in CXC chemokine-mediated angiogenesis, J. Biol. Chem, 270, 27348, 10.1074/jbc.270.45.27348
Siekmann, 2011, The role of chemokines and their receptors in angiogenesis, Cellular and molecular life sciences : CMLS, 68, 2811, 10.1007/s00018-011-0677-7
Strieter, 2007, Chemokines as mediators of angiogenesis, Thromb. Haemost, 97, 755, 10.1160/TH07-01-0040
Richmond, 1997, Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression, J. Leukoc. Biol, 62, 588, 10.1002/jlb.62.5.588
Richmond, 1997, Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins, Int. J. Cancer, 73, 94, 10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5
Singh, 2011, CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation, Microvasc. Res, 82, 318, 10.1016/j.mvr.2011.06.011
Zou, 2005, CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer Res, 65, 465, 10.1158/0008-5472.465.65.2
Moses, 2008, Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis, Cancer cell, 13, 23, 10.1016/j.ccr.2007.12.004
Weber, 1999, Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium, Arterioscler. Thromb. Va c. Biol, 19, 2085, 10.1161/01.ATV.19.9.2085
Karin, 2012, Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis, PloS one, 7, e28305, 10.1371/journal.pone.0028305
Serio, 2001, Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity, J. Clin. Invest, 107, 53, 10.1172/JCI9775
Romagnani, 2003, An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4, J. Exp. Med, 197, 1537, 10.1084/jem.20021897
Strieter, 2004, Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping, J. Immunol, 173, 6234, 10.4049/jimmunol.173.10.6234
Sturzl, 2008, Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy, Int. J. Cancer, 123, 2120, 10.1002/ijc.23764
Tamaya, 2007, Expression of IP-10 related to angiogenesis in uterine cervical cancers, Br. J. Cancer, 96, 1735, 10.1038/sj.bjc.6603790
Richmond, 2004, The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan, Mol Ther, 9, 846, 10.1016/j.ymthe.2004.01.010
Sharpe, 1990, Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides, Science, 247, 77, 10.1126/science.1688470
Richmond, 2002, Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress, J. Leukoc. Biol, 71, 141, 10.1189/jlb.71.1.141
Murdoch, 2009, Neutrophils: key mediators of tumour angiogenesis, Int. J. Exp. Pathol, 90, 222, 10.1111/j.1365-2613.2009.00641.x
Van Damme, 2005, GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors, Exp. Cell Res, 303, 331, 10.1016/j.yexcr.2004.09.027
Hanahan, 2006, Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis, Proc. Natl. Acad. Sci. U. S. A, 103, 12493, 10.1073/pnas.0601807103
Richmond, 2010, Chemokines and chemokine receptors: new insights into cancer-related inflammation, Trends in molecular medicine, 16, 133, 10.1016/j.molmed.2010.01.003
Sica, 2006, Role of tumor-associated macrophages in tumor progression and invasion, Cancer metastasis reviews, 25, 315, 10.1007/s10555-006-9001-7
Pollard, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res, 66, 605, 10.1158/0008-5472.CAN-05-4005
March, 2003, Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors, Circulation, 107, 1164, 10.1161/01.CIR.0000058702.69484.A0
Presta, 2007, Dendritic cell-endothelial cell cross-talk in angiogenesis, Trends in immunology, 28, 385, 10.1016/j.it.2007.07.006
Homey, 2011, Homeostatic chemokine receptors and organ-specific metastasis, Nat Rev Immunol, 11, 597, 10.1038/nri3049
Sedgwick, 2002, CCL27-CCR10 interactions regulate T cell-mediated skin inflammation, Nat. Med, 8, 157, 10.1038/nm0202-157
Fraser, 1970, Patterns of recurrent disease in breast cancer, Lancet, 1, 433
De Baetselier, 1994, Metastatic competence of BW5147 T-lymphoma cell lines is correlated with in vitro invasiveness, motility and F-actin content, J. Leukoc. Biol, 55, 552, 10.1002/jlb.55.4.552
Hwang, 2002, Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells, Cancer Res, 62, 7328
Williamson, 2004, The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis, J. Exp. Ther. Oncol, 4, 291
Blaheta, 2006, CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins, Neoplasia, 8, 290, 10.1593/neo.05694
Taichman, 2003, Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo, J. Cell. Biochem, 89, 462, 10.1002/jcb.10522
Jung, 2011, Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer, Korean J Urol, 52, 607, 10.4111/kju.2011.52.9.607
Schultz, 2012, CXCR4 expression in prostate cancer progenitor cells, PloS one, 7, e31226, 10.1371/journal.pone.0031226
Dwinell, 2008, Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells, Oncogene, 27, 1461, 10.1038/sj.onc.1210751
Shim, 2004, Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4, Cancer Res, 64, 4302, 10.1158/0008-5472.CAN-03-3958
Hung, 2004, Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis, Cancer Cell, 6, 459, 10.1016/j.ccr.2004.09.027
Strieter, 2003, The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases, Am. J. Respir. Crit. Care Med, 167, 1676, 10.1164/rccm.200301-071OC
Xiong, 2005, Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells, Clin. Cancer Res, 11, 8273, 10.1158/1078-0432.CCR-05-0537
Kuppen, 2009, Nuclear localization of CXCR4 determines prognosis for colorectal cancer patients, Cancer Microenviron, 2, 1, 10.1007/s12307-008-0016-1
Dwinell, 2006, Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis, Oncogene, 25, 4986, 10.1038/sj.onc.1209505
Hoon, 2006, Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome, Ann. Surg, 244, 113, 10.1097/01.sla.0000217690.65909.9c
Saiki, 2006, Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer, Cancer Res, 66, 2181, 10.1158/0008-5472.CAN-05-3393
Xu, 2011, CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma, World J Gastroenterol, 17, 2389, 10.3748/wjg.v17.i19.2389
Zhu, 2012, The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis, Med Oncol, 29, 1716, 10.1007/s12032-011-9990-0
Kikkawa, 2008, Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma, Int. J. Cancer, 122, 91, 10.1002/ijc.23083
Yin, 2006, Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression, Gynecol. Oncol, 103, 226, 10.1016/j.ygyno.2006.02.036
Fuse, 2008, Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer, Cancer Sci, 99, 539, 10.1111/j.1349-7006.2007.00712.x
Van Laethem, 2009, High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma, Br. J. Cancer, 100, 1444, 10.1038/sj.bjc.6605020
Allavena, 2004, Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4, Cancer Res, 64, 8420, 10.1158/0008-5472.CAN-04-1343
Scala, 2010, “CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression”, Front Biosci (Elite Ed), 2, 13
Botti, 2010, Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome, Cancer Biol Ther, 9, 423, 10.4161/cbt.9.6.10996
Caraco, 2006, Human melanoma metastases express functional CXCR4, Clin. Cancer Res, 12, 2427, 10.1158/1078-0432.CCR-05-1940
Izbicki, 2005, Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer, J. Natl. Cancer Inst, 97, 1840, 10.1093/jnci/dji431
Fujiwara, 2006, Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer, World J Gastroenterol, 12, 7585, 10.3748/wjg.v12.i47.7585
Harabuchi, 2005, Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma, Clin. Cancer Res, 11, 2937, 10.1158/1078-0432.CCR-04-1470
Siffert, 2005, Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer, Eur. Urol, 47, 111, 10.1016/j.eururo.2004.10.001
Tsuneyoshi, 2006, CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis, Mod. Pathol, 19, 738, 10.1038/modpathol.3800587
Nuchtern, 2004, CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases, J. Pediatr. Surg, 39, 1506, 10.1016/j.jpedsurg.2004.06.019
Ransohoff, 2007, Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?, Neurotherapeutics, 4, 590, 10.1016/j.nurt.2007.07.004
Shigemori, 2011, CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target, Brain Tumor Pathol, 28, 89, 10.1007/s10014-010-0013-1
Seeger, 2006, Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse, J. Pediatr. Hematol. Oncol, 28, 216, 10.1097/01.mph.0000212908.14642.a5
Huang, 2011, Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma, Chin J Cancer, 30, 336, 10.5732/cjc.010.10490
Bordignon, 2010, Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses, Nat. Med, 16, 98, 10.1038/nm.2074
Broxmeyer, 1999, CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors, Cell. Immunol, 193, 226, 10.1006/cimm.1999.1483
Yoshie, 1998, EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC, Int. Immunol, 10, 901, 10.1093/intimm/10.7.901
Inaba, 1997, Dendritic cells in the T-cell areas of lymphoid organs, Immunol. Rev, 156, 25, 10.1111/j.1600-065X.1997.tb00956.x
Nakano, 1999, Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization, J. Exp. Med, 189, 451, 10.1084/jem.189.3.451
Volm, 1996, Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma, Br. J. Cancer, 73, 931, 10.1038/bjc.1996.166
Imamura, 2003, Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma, Clin. Cancer Res, 9, 3406
Hoon, 2004, CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells, Clin. Cancer Res, 10, 2351, 10.1158/1078-0432.CCR-03-0195
Takanami, 2003, Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis, Int. J. Cancer, 105, 186, 10.1002/ijc.11063
Hoffmann, 2006, Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy, Int. J. Cancer, 118, 2147, 10.1002/ijc.21514
Mori, 2002, Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma, Cancer Res, 62, 2937
Forster, 2005, Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7, Int. J. Cancer, 116, 726, 10.1002/ijc.21123
Vines, 2010, Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice, Transl Oncol, 3, 354, 10.1593/tlo.10178
Hwang, 2001, Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma, J. Natl. Cancer Inst, 93, 1638, 10.1093/jnci/93.21.1638
Bates, 2011, CCR7 mediates directed growth of melanomas towards lymphatics, Microcirculation, 18, 172, 10.1111/j.1549-8719.2010.00074.x
Sun, 2011, Effect of chemokine receptors CCR7 on disseminated behavior of human T cell lymphoma: clinical and experimental study, J. Exp. Clin. Cancer Res, 30, 51, 10.1186/1756-9966-30-51
Sipos, 2012, Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma, Int. J. Cancer, 131, E371, 10.1002/ijc.26502
Sun, 2011, Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin alphavbeta3, Int. J. Mol. Med, 27, 679, 10.3892/ijmm.2011.628
Sun, 2010, Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis, J. Exp. Clin. Cancer Res, 29, 16, 10.1186/1756-9966-29-16
Sahin, 2005, CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer, Clin. Cancer Res, 11, 5686, 10.1158/1078-0432.CCR-05-0014
Aikou, 2009, CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer, Int. J. Oncol, 35, 19
Hiramatsu, 2007, Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer, Ann. Oncol, 18, 70, 10.1093/annonc/mdl342
Munoz, 2004, Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination, J. Leukoc. Biol, 76, 462, 10.1189/jlb.1203652
Gatter, 1994, A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group, Blood, 84, 1361, 10.1182/blood.V84.5.1361.1361
Aster, 2004, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, 306, 269, 10.1126/science.1102160
Lipp, 2009, CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia, Nature, 459, 1000, 10.1038/nature08020
Ferris, 2012, Chemokine receptor 7 (CCR7) gene expression is regulated by NF-kappaB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN), J. Biol. Chem, 287, 3581, 10.1074/jbc.M111.294876
Sun, 2011, NF-kappaB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck, Oncol. Rep, 25, 383, 10.3892/or.2010.1090
Ferris, 2005, Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR, Oncogene, 24, 5897, 10.1038/sj.onc.1208740
Ferris, 2006, CCR7 mediates inflammation-associated tumor progression, Immunol. Res, 36, 61, 10.1385/IR:36:1:61
Parker, 1999, Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis, J. Exp. Med, 190, 1241, 10.1084/jem.190.9.1241
Naquet, 2000, The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9, Eur. J. Immunol, 30, 262, 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0
Kelvin, 2001, Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance, Am. J. Gastroenterol, 96, 2392, 10.1111/j.1572-0241.2001.04041.x
Mihas, 2001, Small intestinal neoplasms, J. Clin. Gastroenterol, 33, 267, 10.1097/00004836-200110000-00004
Kochman, 1999, Melanoma in the gastrointestinal tract, Am. J. Gastroenterol, 94, 3427, 10.1111/j.1572-0241.1999.01604.x
Scheibenbogen, 2004, Functional CCR9 expression is associated with small intestinal metastasis, J. Invest. Dermatol, 122, 685, 10.1111/j.0022-202X.2004.22315.x
Hoon, 2008, Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine, Clin. Cancer Res, 14, 638, 10.1158/1078-0432.CCR-07-2025
Lillard, 2011, CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion, Int. J. Oncol, 38, 1279, 10.3892/ijo.2011.953
Singh, 2011, Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer, Int. J. Oncol, 39, 373
Zlotnik, 2000, Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC), J. Immunol, 164, 3465, 10.4049/jimmunol.164.7.3465
Cornelius, 2002, The role of chemokines in melanoma tumor growth and metastasis, J. Invest. Dermatol, 118, 915, 10.1046/j.1523-1747.2002.01725.x
Offidani, 2006, Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape, Eur. J. Cancer, 42, 1181, 10.1016/j.ejca.2006.01.043
Sato, 2011, CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma, Pathol. Res. Pract, 207, 43, 10.1016/j.prp.2010.10.007
Llombart-Bosch, 2007, CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors, J. Clin. Pathol, 60, 596, 10.1136/jcp.2005.032144
Taketo, 2004, Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes, Cancer Res, 64, 4010, 10.1158/0008-5472.CAN-03-1757
Kuroki, 2008, Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma, Oncol. Rep, 19, 1461
Taketo, 2007, Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes, Oncogene, 26, 4679, 10.1038/sj.onc.1210267
Schmid-Alliana, 2009, Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism, Br. J. Cancer, 100, 1755, 10.1038/sj.bjc.6605078
Sakai, 2013, The role of CXCR3 and CXCR4 in colorectal cancer metastasis, Int. J. Cancer, 132, 276, 10.1002/ijc.27670
Schmid-Antomarchi, 2009, Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs, Int. J. Cancer, 125, 2586, 10.1002/ijc.24665
Fulton, 2006, Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer, Cancer Res, 66, 7701, 10.1158/0008-5472.CAN-06-0709
Cyster, 2000, A chemokine-driven positive feedback loop organizes lymphoid follicles, Nature, 406, 309, 10.1038/35018581
Cyster, 2002, Chemokine requirements for B cell entry to lymph nodes and Peyer's patches, J. Exp. Med, 196, 65, 10.1084/jem.20020201
Pistoia, 2008, CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow, Cancer Immunol. Immunother, 57, 541, 10.1007/s00262-007-0392-2
Liu, 2011, High-level CXCR4 expression correlates with brain-specific metastasis of non-small cell lung cancer, World J. Surg, 35, 56, 10.1007/s00268-010-0784-x
Cavallaro, 2011, CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases, Cancer Biomark, 10, 79
Avraham, 2004, Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells, Mol. Cancer Res, 2, 327, 10.1158/1541-7786.327.2.6
Cristofanilli, 2006, Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer, Ann. Oncol, 17, 945, 10.1093/annonc/mdl053